Short Interest in Movano Inc. (NASDAQ:MOVE) Drops By 29.1%

Movano Inc. (NASDAQ:MOVE) saw a significant decline in short interest in the month of December. As of December 31st, there was short interest totaling 43,438 shares, a decline of 29.1% from the December 15th total of 61,231 shares. Currently, 5.8% of the company’s shares are sold short. Based on an average daily trading volume, of 83,145 shares, the days-to-cover ratio is presently 0.5 days. Based on an average daily trading volume, of 83,145 shares, the days-to-cover ratio is presently 0.5 days. Currently, 5.8% of the company’s shares are sold short.

Movano Stock Performance

Movano stock traded up $0.13 during trading hours on Friday, hitting $7.16. The company had a trading volume of 11,258 shares, compared to its average volume of 54,631. The firm has a market cap of $5.94 million, a P/E ratio of -0.66 and a beta of 0.79. The company has a 50-day moving average price of $8.97 and a two-hundred day moving average price of $7.57. Movano has a 1 year low of $4.67 and a 1 year high of $58.76.

Movano (NASDAQ:MOVE) last posted its quarterly earnings results on Friday, November 14th. The technology company reported ($4.73) earnings per share for the quarter, beating the consensus estimate of ($7.00) by $2.27. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%. The firm had revenue of $0.08 million during the quarter, compared to the consensus estimate of $3.88 million.

Movano News Roundup

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Institutional interest: Citadel Advisors disclosed a new, small stake in Movano (49,262 shares), which signals some institutional conviction and provides modest demand support for the thinly traded name. MarketBeat MOV E profile
• Positive Sentiment: Falling short interest: short interest declined in late December (helping reduce one technical headwind and lowering one source of immediate downside pressure). MarketBeat short interest
• Neutral Sentiment: Broader market/geopolitical weakness: wider market pullbacks and geopolitical headlines are hitting small-cap and tech names harder today, likely amplifying Movano’s move. This is a market-driven headwind rather than company-specific news. RTT News: Market Move
• Negative Sentiment: Clustered insider selling: CTO Michael Leabman sold multiple tranches this month (e.g., 6,845 shares on Jan. 14 at ~$6.66; additional sales Jan. 12–13). Large, concentrated insider sales in a tiny, low‑float stock weigh heavily on sentiment and can trigger further price pressure. SEC filing (Leabman)
• Negative Sentiment: Additional insider sales: CFO Jeremy Cogan also disclosed recent sales (including 8,218 shares on Jan. 6), further reducing insider ownership and reinforcing negative market perception. SEC filing (Cogan)
• Negative Sentiment: Weak fundamentals and tiny scale: the recent quarter showed a large EPS loss despite beating the consensus loss, with essentially negligible revenue (~$0.08M versus the street estimate). For a micro‑cap with a market cap in the single‑digit millions and low liquidity, execution risk and potential dilution remain real concerns. Earnings summary
• Negative Sentiment: Analyst/structural headwinds: small market cap, thin volume, and a consensus skewed toward “Sell” make sustained rebounds difficult absent clear operational progress or meaningful new revenue evidence. Company profile & ratings

Insiders Place Their Bets

In related news, CFO Jeremy Cogan sold 8,218 shares of Movano stock in a transaction dated Tuesday, January 6th. The shares were sold at an average price of $7.79, for a total transaction of $64,018.22. Following the completion of the transaction, the chief financial officer directly owned 15,107 shares of the company’s stock, valued at approximately $117,683.53. The trade was a 35.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CTO Michael Aaron Leabman sold 6,845 shares of the company’s stock in a transaction dated Wednesday, January 14th. The shares were sold at an average price of $6.66, for a total transaction of $45,587.70. Following the transaction, the chief technology officer owned 22,639 shares in the company, valued at $150,775.74. The trade was a 23.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 32,578 shares of company stock worth $239,964 in the last quarter. Company insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Movano

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC purchased a new stake in shares of Movano Inc. (NASDAQ:MOVE) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano at the end of the most recent quarter. 16.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Movano in a research report on Wednesday, October 8th. Wall Street Zen lowered Movano from a “hold” rating to a “sell” rating in a research note on Saturday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.